Literature DB >> 28120007

[Influence of dose and fractionation in radiation therapy of curative intent for non-small cell lung cancer].

Carsten Nieder1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28120007     DOI： 10.1007/s00066-017-1096-y

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  11 in total

1.  Combining advanced radiotherapy technologies to maximize safety and tumor control probability in stage III non-small cell lung cancer.

Authors:  M Guckenberger; A Kavanagh; M Partridge
Journal:  Strahlenther Onkol       Date:  2012-08-31       Impact factor: 3.621

2.  SPACE - A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC.

Authors:  Jan Nyman; Andreas Hallqvist; Jo-Åsmund Lund; Odd-Terje Brustugun; Bengt Bergman; Per Bergström; Signe Friesland; Rolf Lewensohn; Erik Holmberg; Ingmar Lax
Journal:  Radiother Oncol       Date:  2016-09-03       Impact factor: 6.280

3.  Long-term results of high-dose conformal radiotherapy for patients with medically inoperable T1-3N0 non-small-cell lung cancer: is low incidence of regional failure due to incidental nodal irradiation?

Authors:  Ming Chen; James A Hayman; Randall K Ten Haken; Daniel Tatro; Shaneli Fernando; Feng-Ming Kong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-09-29       Impact factor: 7.038

4.  Dose, volume, and tumor control prediction in primary radiotherapy of non-small-cell lung cancer.

Authors:  Jochen Willner; Kurt Baier; Ekaterini Caragiani; Axel Tschammler; Michael Flentje
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-02-01       Impact factor: 7.038

5.  Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.

Authors:  Jeffrey D Bradley; Rebecca Paulus; Ritsuko Komaki; Gregory Masters; George Blumenschein; Steven Schild; Jeffrey Bogart; Chen Hu; Kenneth Forster; Anthony Magliocco; Vivek Kavadi; Yolanda I Garces; Samir Narayan; Puneeth Iyengar; Cliff Robinson; Raymond B Wynn; Christopher Koprowski; Joanne Meng; Jonathan Beitler; Rakesh Gaur; Walter Curran; Hak Choy
Journal:  Lancet Oncol       Date:  2015-01-16       Impact factor: 41.316

6.  Improved survival with dose-escalated radiotherapy in stage III non-small-cell lung cancer: analysis of the National Cancer Database.

Authors:  J V Brower; A Amini; S Chen; C R Hullett; R J Kimple; A P Wojcieszynski; M Bassetti; M E Witek; M Yu; P M Harari; A M Baschnagel
Journal:  Ann Oncol       Date:  2016-08-08       Impact factor: 32.976

7.  Treatment-Related Death during Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Studies.

Authors:  Jing Zhao; Yingfeng Xia; Joseph Kaminski; Zhonglin Hao; Frank Mott; Jeff Campbell; Ramses Sadek; Feng-Ming Spring Kong
Journal:  PLoS One       Date:  2016-06-14       Impact factor: 3.240

Review 8.  A critical review of recent developments in radiotherapy for non-small cell lung cancer.

Authors:  Sarah Baker; Max Dahele; Frank J Lagerwaard; Suresh Senan
Journal:  Radiat Oncol       Date:  2016-09-06       Impact factor: 3.481

9.  PRONTOX - proton therapy to reduce acute normal tissue toxicity in locally advanced non-small-cell lung carcinomas (NSCLC): study protocol for a randomised controlled trial.

Authors:  Sebastian Zschaeck; Monique Simon; Steffen Löck; Esther G C Troost; Kristin Stützer; Patrick Wohlfahrt; Steffen Appold; Sebastian Makocki; Rebecca Bütof; Christian Richter; Michael Baumann; Mechthild Krause
Journal:  Trials       Date:  2016-11-15       Impact factor: 2.279

10.  Dose and Fractionation in Radiation Therapy of Curative Intent for Non-Small Cell Lung Cancer: Meta-Analysis of Randomized Trials.

Authors:  Johanna Ramroth; David J Cutter; Sarah C Darby; Geoff S Higgins; Paul McGale; Mike Partridge; Carolyn W Taylor
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-07-25       Impact factor: 7.038
View more
  1 in total

1.  Is in vivo and ex vivo irradiation equally reliable for individual Radiosensitivity testing by three colour fluorescence in situ hybridization?

Authors:  Theresa Mayo; Marlen Haderlein; Barbara Schuster; Anna Wiesmüller; Christian Hummel; Maximilian Bachl; Manfred Schmidt; Rainer Fietkau; Luitpold Distel
Journal:  Radiat Oncol       Date:  2019-12-31       Impact factor: 3.481
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.